SE384211B - Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner - Google Patents
Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazolinerInfo
- Publication number
- SE384211B SE384211B SE7105610A SE561071A SE384211B SE 384211 B SE384211 B SE 384211B SE 7105610 A SE7105610 A SE 7105610A SE 561071 A SE561071 A SE 561071A SE 384211 B SE384211 B SE 384211B
- Authority
- SE
- Sweden
- Prior art keywords
- trialcoxikinazolines
- amino
- substituted
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3954170A | 1970-05-21 | 1970-05-21 | |
US24086572A | 1972-04-03 | 1972-04-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE384211B true SE384211B (sv) | 1976-04-26 |
Family
ID=26716233
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7105610A SE384211B (sv) | 1970-05-21 | 1971-04-29 | Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner |
SE7314685A SE400280B (sv) | 1970-05-21 | 1973-10-29 | 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7314685A SE400280B (sv) | 1970-05-21 | 1973-10-29 | 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner |
Country Status (10)
Country | Link |
---|---|
US (2) | US3669968A (de) |
JP (1) | JPS5268191A (de) |
AT (1) | AT308120B (de) |
BE (1) | BE766444A (de) |
CH (1) | CH521353A (de) |
DE (2) | DE2120495C2 (de) |
FR (1) | FR2092154B1 (de) |
GB (1) | GB1309835A (de) |
NL (1) | NL178594C (de) |
SE (2) | SE384211B (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3980650A (en) * | 1972-05-05 | 1976-09-14 | N.V. Koninklijke Pharmaceutische Fabrieken V/H Brocades-Stheeman En Pharmacia | 4-Amino-pyrimidine derivatives |
GB1383409A (en) * | 1972-09-09 | 1974-02-12 | Pfizer Ltd | Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them |
JPS4966691A (de) * | 1972-10-30 | 1974-06-27 | ||
US4026894A (en) * | 1975-10-14 | 1977-05-31 | Abbott Laboratories | Antihypertensive agents |
US4060615A (en) * | 1976-02-18 | 1977-11-29 | Mead Johnson & Company | 2-Piperazinyl-6,7-dimethoxyquinazolines |
DK140695C (da) | 1976-05-07 | 1980-05-12 | Synthelabo | Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf |
SE435380B (sv) | 1976-06-15 | 1984-09-24 | Pfizer | Forfarande for framstellning av kinazolinforeningar |
US4171363A (en) * | 1977-02-22 | 1979-10-16 | Bristol-Myers Company | 1,2,3-Thiadiazole process |
US4101548A (en) * | 1977-02-22 | 1978-07-18 | Bristol-Myers Company | 1,2,3-Thiadiazole amides |
US4098788A (en) * | 1977-06-20 | 1978-07-04 | Bristol-Myers Company | Process for preparing quinazolines |
US4102885A (en) * | 1977-06-20 | 1978-07-25 | Bristol-Myers Company | Process for preparing 2,4-dihaloquinazolines |
US4130647A (en) * | 1977-07-08 | 1978-12-19 | Pfizer Inc. | Methods for treating congestive heart failure and ischemic heart disease |
DK154082C (da) * | 1977-11-05 | 1989-02-27 | Pfizer | Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf |
US4188390A (en) * | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
US4287341A (en) * | 1979-11-01 | 1981-09-01 | Pfizer Inc. | Alkoxy-substituted-6-chloro-quinazoline-2,4-diones |
US4377581A (en) * | 1980-03-03 | 1983-03-22 | Pfizer Inc. | Chloro- and alkoxy-substituted-2,4-diaminoquinazolines |
US4351940A (en) * | 1980-03-03 | 1982-09-28 | Pfizer Inc. | Chloro- and alkoxy-substituted-2-chloro-4-aminodquinazolines |
US4510307A (en) * | 1980-08-20 | 1985-04-09 | Asahi Kasei Kogyo Kabushiki Kaisha | 6-Quinazolinesulfonyl derivatives and process for preparation thereof |
FI70411C (fi) | 1980-12-29 | 1986-09-19 | Pfizer | Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat |
US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
US4582832A (en) * | 1984-10-09 | 1986-04-15 | Pfizer Inc. | Trimazosin as an anti-atherosclerosis agent |
GB8910722D0 (en) * | 1989-05-10 | 1989-06-28 | Smithkline Beckman Intercredit | Compounds |
PT100905A (pt) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
DE69406945T2 (de) * | 1993-10-18 | 1998-03-12 | Ici Plc | Katalytisches verfahren |
BR0114020A (pt) * | 2000-09-20 | 2003-07-22 | Merck Patent Gmbh | 4-amino-quinazolinas |
MXPA05001958A (es) | 2002-08-19 | 2005-04-28 | Pfizer Prod Inc | Terapia de combinacion para enfermedades hiperproliferativas. |
WO2004052862A1 (ja) * | 2002-12-10 | 2004-06-24 | Ono Pharmaceutical Co., Ltd. | 含窒素複素環化合物およびその医薬用途 |
EA009646B1 (ru) * | 2003-05-30 | 2008-02-28 | Рэнбакси Лабораториз Лтд. | Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa |
US20050037063A1 (en) * | 2003-07-21 | 2005-02-17 | Bolton Anthony E. | Combined therapies |
EP1768964A1 (de) * | 2004-07-06 | 2007-04-04 | Angion Biomedica Corporation | Chinazolinmodulatoren des hepatozytenwachstumsfaktors/der c-met-aktivität für die behandlung von krebs |
US20060063803A1 (en) * | 2004-09-23 | 2006-03-23 | Pfizer Inc | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
AU2006313430B2 (en) * | 2005-11-08 | 2012-09-06 | Ranbaxy Laboratories Limited | Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US20070213319A1 (en) * | 2006-01-11 | 2007-09-13 | Angion Biomedica Corporation | Modulators of hepatocyte growth factor/c-Met activity |
US7919506B2 (en) | 2006-03-10 | 2011-04-05 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
TW200744583A (en) * | 2006-03-14 | 2007-12-16 | Ranbaxy Lab Ltd | Statin stabilizing dosage formulations |
MX2009000439A (es) * | 2006-07-14 | 2009-02-04 | Ranbaxy Lab Ltd | Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas. |
CN101663262B (zh) | 2006-12-01 | 2014-03-26 | 百时美施贵宝公司 | 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物 |
CN105143203A (zh) | 2013-04-17 | 2015-12-09 | 辉瑞大药厂 | 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
CN113574055B (zh) | 2019-01-18 | 2024-07-23 | 阿斯利康(瑞典)有限公司 | Pcsk9抑制剂及其使用方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1156973A (en) * | 1965-07-06 | 1969-07-02 | Quinazoline Derivatives |
-
1970
- 1970-05-21 US US39541A patent/US3669968A/en not_active Expired - Lifetime
- 1970-09-09 GB GB4323070A patent/GB1309835A/en not_active Expired
-
1971
- 1971-04-27 DE DE2120495A patent/DE2120495C2/de not_active Expired
- 1971-04-27 DE DE2167157A patent/DE2167157C2/de not_active Expired
- 1971-04-28 FR FR7115185A patent/FR2092154B1/fr not_active Expired
- 1971-04-29 SE SE7105610A patent/SE384211B/xx unknown
- 1971-04-29 BE BE766444A patent/BE766444A/xx not_active IP Right Cessation
- 1971-04-29 CH CH634571A patent/CH521353A/fr not_active IP Right Cessation
- 1971-04-30 AT AT374771A patent/AT308120B/de not_active IP Right Cessation
- 1971-05-03 NL NLAANVRAGE7106029,A patent/NL178594C/xx not_active IP Right Cessation
-
1972
- 1972-04-03 US US00240865A patent/US3769286A/en not_active Expired - Lifetime
-
1973
- 1973-10-29 SE SE7314685A patent/SE400280B/xx unknown
-
1976
- 1976-09-27 JP JP51115730A patent/JPS5268191A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
GB1309835A (en) | 1973-03-14 |
US3669968A (en) | 1972-06-13 |
DE2120495A1 (de) | 1971-12-02 |
JPS5268191A (en) | 1977-06-06 |
US3769286A (en) | 1973-10-30 |
SE400280B (sv) | 1978-03-20 |
FR2092154B1 (de) | 1975-01-17 |
DE2167157C2 (de) | 1982-06-09 |
NL178594C (nl) | 1986-04-16 |
FR2092154A1 (de) | 1972-01-21 |
JPS5439386B2 (de) | 1979-11-27 |
AT308120B (de) | 1973-06-25 |
NL7106029A (de) | 1971-11-23 |
CH521353A (fr) | 1972-04-15 |
NL178594B (nl) | 1985-11-18 |
BE766444A (fr) | 1971-10-29 |
DE2120495C2 (de) | 1982-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE384211B (sv) | Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner | |
SE384368B (sv) | Forfarande for framstellning av 6-substituerade - 4 - amino- 1,2 - dihydro - 1 - hydroxi - 2 - iminopyrimidiner | |
SE409708B (sv) | Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidiner | |
SE385885B (sv) | Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat | |
SE7409801L (sv) | Forfarande for framstellning av kinolinforeningar. | |
NO138883C (no) | Fremgangsmaate for fremstilling av oksiranforbindelser | |
RO71354A (ro) | Procedeu pentru prepararea unor p-halofenil-2-pirolidinone | |
SE399701B (sv) | Forfarande for framstellning av hydroxyalkyldiamin | |
SE394436B (sv) | Forfarande for framstellning av 7-halogen-linkomyciner | |
SE380273B (sv) | Forfarande for framstellning av tiopyrimidinderivat | |
SE385011B (sv) | Forfarande for framstellning av alfa-linkosaminider | |
SE400768B (sv) | Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon | |
SE389105B (sv) | Forfarande for framstellning av vissa angivna ketaziner | |
SE7505279L (sv) | Forfarande for framstellning av hydroxipyrimidiner. | |
SE386175B (sv) | Forfarande for framstellning av 1,4-bis-acylpiperaziner | |
SE408418B (sv) | Forfarande for framstellning av 5-fluor-pyrimidiner | |
SE388611B (sv) | Analogiforfarande for framstellning av 1,4-bensodiazeponderivat | |
SE406587B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin | |
SE395699B (sv) | Forfarande for framstellning av kinuklidin-kinolinderivat | |
SE390025B (sv) | Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion | |
SE380795B (sv) | Forfarande for framstellning av tiokarbamider | |
SE398753B (sv) | Forfarande for framstellning av 3',4'-didesoxitanamycin b | |
SE411759B (sv) | Forfarande for framstellning av erytromycyliminforeningar | |
SE389333B (sv) | Forfarande for framstellning av ackalipolyfosfatkomplex av x-6-desoxi-5-hydroxitetsacyklin. | |
SE382046B (sv) | Forfarande for framstellning av 1-aryloxi-2-propanol |